Assessment of a point-of-care device for measuring creatinine in a community screening program for chronic kidney disease

Main Article Content

Brooke Ann Spaeth Anne K Shephard Mark DS Shephard Timothy H Mathew




Background: Chronic kidney disease (CKD) is a major contemporary global health problem. Creatinine measurement for the calculation of estimated glomerular filtration rate is an important component of assessing CKD risk. A point-of-care test for creatinine using capillary sampling is required as part of a screening assessment.


Objectives: Evaluate the analytical performance of a modified point-of-care testing method for whole blood creatinine (Nova Biomedical StatSensor whole blood creatinine analyser) relative to a laboratory method.


Design and methods: Conduct a patient comparison study between the point-of-care testing and laboratory methods in a rural community setting. Calculate measures of imprecision and assess the ability of the POCT method to determine staging of CKD compared to the laboratory.


Results: Between-device imprecision averaged 8.8%. The StatSensor devices showed a positive bias of approximately 14% for whole blood creatinine measurement compared to the laboratory method, leading to more than 40% of community patients being staged differently for CKD risk with approximately 25% more abnormal results.


Conclusions: The StatSensor whole blood creatinine point-of-care device remains analytically unsound for use as a screening device for CKD.

Article Details

How to Cite
SPAETH, Brooke Ann et al. Assessment of a point-of-care device for measuring creatinine in a community screening program for chronic kidney disease. Medical Research Archives, [S.l.], n. 3, may 2015. ISSN 2375-1924. Available at: <>. Date accessed: 07 oct. 2022.
chronic kidney disease; point-of-care testing; creatinine; estimated glomerular filtration rate
Research Articles


[1] Eckhardt K-U, Coresh J, Devuyst O, Johnson R, Kottgen A, Levey A et al. (2013). Evolving importance of kidney disease: from subspecialty to global health burden. Lancet, 382: 158-169.

[2] Jha V, Garcia-Garcia G, Iseli K, Li Z, Naiker S, Plattner B et al. (2013). Chronic kidney disease; global dimension and perspectives. Lancet, 382: 260-272.

[3] Jha V, Wang A-M, Wang H. (2012). The impact of CKD identification in larger countries: the burden of illness. Nephrol Dialysis Transplant, 27: 32-38.

[4] Levey A, Coresh J. (2012). Chronic kidney disease. Lancet, 379: 165-180.

[5] Ayodele O, Alebiousi C. (2010). Burden of chronic kidney disease; an international perspective. Adv Chronic Kid Dis, 17: 215-224.

[6] Couser W, Remuzzi G, Mendis S, Tonelli M. (2011). The contribution of chronic disease to the global burden of major non-communicable diseases. Kidney Int, 80: 1258-1270.

[7] Chronic kidney disease (CKD) management in general practice (2nd edition). Kidney Health Australia, Melbourne 2012. Available at [last accessed 1 September 2014].

[8] Mathew T, Corso O, Ludlow M, Boyle A, Cass A, Chadban S, et al. (2010). Screening for chronic kidney disease in Australia: a pilot study in the community and workplace. Kidney Int, 77 (Supp 116): S9-S16.

[9] Shephard A, Shephard M, Halls H, Corso O, Mathew T. (2011). Innovative use of point-of-care testing for chronic kidney disease screening. Point of Care, 10: 98-101.

[10] Polkinghorne K. (2014). Estimated glomerular filtration rate versus albuminuria in the assessment of kidney function: What’s more important? Clin Biochem Revs, 35: 67-73.

[11] Shephard M. (2011). Point-of-care testing and creatinine measurement. Clin Biochem Revs, 32: 109-114.

[12] Peake M, Whiting M. (2006). Measurement of serum creatinine – current status and future goals. Clin Biochem Revs, 27:173-84.
[13] Shephard MD, Peake MJ, Corso O, Shephard AK, Mazzachi BC, Spaeth BA et al. (2010). Assessment of the NovaStatSensor whole blood point-of-care creatinine analyser for the measurement of kidney function in screening for chronic kidney disease. Clin Chem Lab Med, 48: 1113-1119.

[14] Australian Bureau of Statistics (2011). Information Paper: Census of Population and Housing -- Products and Services, 2011 (cat. no. 2011.0.55.001). Available at [last accessed 8 September 2014].

[15] Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH et al. (2012). Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA, 37 (18) 1941-1951.